J Kuiper

Author PubWeight™ 71.57‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Neuroimmunol 1996 2.34
2 The blood-brain barrier in neuroinflammatory diseases. Pharmacol Rev 1997 1.73
3 Vascular adhesion molecule-1 and intercellular adhesion molecule-1 expression on rat liver cells after lipopolysaccharide administration in vivo. Hepatology 1995 1.69
4 The impact and recovery of asteroid 2008 TC(3). Nature 2009 1.60
5 Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat gram-negative sepsis. J Biol Chem 2001 1.59
6 Structural characterisation of the exopolysaccharide produced by Lactobacillus delbrückii subspecies bulgaricus rr grown in skimmed milk. Carbohydr Res 1993 1.49
7 Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis. Circulation 2006 1.41
8 Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice. Biochem Biophys Res Commun 2009 1.36
9 Attenuation of atherogenesis by systemic and local adenovirus-mediated gene transfer of interleukin-10 in LDLr-/- mice. FASEB J 2001 1.31
10 Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. J Biol Chem 1990 1.24
11 Hormonal control of glycogenolysis in parenchymal liver cells by Kupffer and endothelial liver cells. J Biol Chem 1988 1.21
12 FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity. Nat Med 2000 1.19
13 Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo. J Clin Invest 1997 1.18
14 Structure of the exopolysaccharide produced by Lactococcus lactis subspecies cremoris H414 grown in a defined medium or skimmed milk. Carbohydr Res 1992 1.17
15 Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting. Adv Drug Deliv Rev 2001 1.17
16 Fate and effects of 4-chlorophenol and 2,4-dichlorophenol in marine plankton communities in experimental enclosures. Ecotoxicol Environ Saf 1984 1.08
17 Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient mice. Arterioscler Thromb Vasc Biol 2004 1.07
18 Hepatic and extrahepatic scavenger receptors: function in relation to disease. Arterioscler Thromb Vasc Biol 2000 1.06
19 Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis. Circulation 2005 1.06
20 Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis. Arterioscler Thromb Vasc Biol 2007 1.05
21 Endotoxin stimulates glycogenolysis in the liver by means of intercellular communication. J Biol Chem 1988 1.04
22 Effect of endotoxin on permeability of bovine cerebral endothelial cell layers in vitro. J Pharmacol Exp Ther 1996 1.03
23 Eicosanoid production by rat cerebral endothelial cells: stimulation by lipopolysaccharide, interleukin-1 and interleukin-6. J Neuroimmunol 1995 1.01
24 Receptor-mediated endocytosis of tissue-type plasminogen activator (t-PA) by liver cells. Thromb Res Suppl 1990 1.01
25 Conditioned media of Kupffer and endothelial liver cells influence protein phosphorylation in parenchymal liver cells. Involvement of prostaglandins. Biochem J 1988 1.00
26 Differential effects of regulatory T cells on the initiation and regression of atherosclerosis. Atherosclerosis 2011 0.99
27 Prostaglandin D2 mediates the stimulation of glycogenolysis in the liver by phorbol ester. Biochem J 1988 0.97
28 New scavenger receptor-like receptors for the binding of lipopolysaccharide to liver endothelial and Kupffer cells. Infect Immun 1998 0.96
29 Genome-wide expression studies of atherosclerosis: critical issues in methodology, analysis, interpretation of transcriptomics data. Arterioscler Thromb Vasc Biol 2006 0.93
30 Lymphocyte adhesion to brain capillary endothelial cells in vitro. J Neuroimmunol 1994 0.92
31 Scavenger receptor-like receptors for the binding of lipopolysaccharide and lipoteichoic acid to liver endothelial and Kupffer cells. J Endotoxin Res 2001 0.92
32 Ligand size is a major determinant of high-affinity binding of fucose- and galactose-exposing (lipo)proteins by the hepatic fucose receptor. Biochem J 1994 0.91
33 IgG subclass response to Helicobacter pylori in patients with chronic active gastritis and duodenal ulcer. Scand J Gastroenterol 1992 0.90
34 Normative sexual behavior in children. Pediatrics 1991 0.89
35 Seal vaccination success. Nature 1989 0.89
36 Liver uptake of phosphodiester oligodeoxynucleotides is mediated by scavenger receptors. Mol Pharmacol 1998 0.88
37 Lysine-based cluster mannosides that inhibit ligand binding to the human mannose receptor at nanomolar concentration. J Biol Chem 1996 0.88
38 Vaccination against Foxp3(+) regulatory T cells aggravates atherosclerosis. Atherosclerosis 2009 0.88
39 Characterization in vitro of interaction of human apolipoprotein E-free high density lipoprotein with human hepatocytes. Arteriosclerosis 1990 0.88
40 Delivery of Chlamydia pneumoniae to the vessel wall aggravates atherosclerosis in LDLr-/- mice. Cardiovasc Res 2005 0.88
41 Interleukin-1 receptors on rat brain endothelial cells: a role in neuroimmune interaction? FASEB J 1996 0.87
42 T-cell co-stimulation by CD28-CD80/86 and its negative regulator CTLA-4 strongly influence accelerated atherosclerosis development. Int J Cardiol 2013 0.87
43 Different zonal distribution of the asialoglycoprotein receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein and the lipoprotein-remnant receptor of rat liver parenchymal cells. Biochem J 1994 0.86
44 Targeted delivery of oligodeoxynucleotides to parenchymal liver cells in vivo. Biochem J 1999 0.86
45 Vaccination strategies in atherosclerosis. Thromb Haemost 2011 0.85
46 Antagonists of the mannose receptor and the LDL receptor-related protein dramatically delay the clearance of tissue plasminogen activator. Circulation 1997 0.84
47 Oxidized low-density lipoprotein as a delivery system for photosensitizers: implications for photodynamic therapy of atherosclerosis. J Pharmacol Exp Ther 1999 0.84
48 Vaccination of harbour seals (Phoca vitulina) against phocid distemper with two different inactivated canine distemper virus (CDV) vaccines. Vaccine 1989 0.84
49 Characterization of the interaction of acetylated LDL and oxidatively modified LDL with human liver parenchymal and Kupffer cells in culture. Arterioscler Thromb 1992 0.84
50 Lipoprotein receptors and atherogenic receptor-mediated mechanisms. Curr Opin Lipidol 1994 0.82
51 Flow-through viscometer for use in the automated determination of hydrolytic enzyme activities: application in protease, amylase, and pectinase assays. Anal Biochem 1978 0.82
52 Acute effects of oxidized low density lipoprotein on metabolic responses in macrophages. FASEB J 1998 0.82
53 Fracture after cardiac transplantation: a prospective longitudinal study. J Clin Endocrinol Metab 1996 0.81
54 Beta-migrating very-low-density lipoproteins and chylomicron remnants bind to rat liver hepatocytes at a low-density-lipoprotein-receptor-independent site (the remnant receptor). Biochem J 1995 0.81
55 Isolation and characterization of the mannose receptor from human liver potentially involved in the plasma clearance of tissue-type plasminogen activator. Hepatology 1992 0.80
56 Characterization of the interaction both in vitro and in vivo of tissue-type plasminogen activator (t-PA) with rat liver cells. Effects of monoclonal antibodies to t-PA. Biochem J 1992 0.80
57 High-density lipoprotein and cerebral endothelial cells in vitro: interactions and transport. Biochem Pharmacol 1995 0.80
58 Uptake and degradation of human low-density lipoprotein by human liver parenchymal and Kupffer cells in culture. Biochem J 1991 0.80
59 An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation. Arterioscler Thromb Vasc Biol 2013 0.79
60 Specific interaction of oxidized low-density lipoprotein with macrophage-derived foam cells isolated from rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1999 0.78
61 Blockade of the alpha 2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein on rat liver parenchymal cells by the 39-kDa receptor-associated protein leaves the interaction of beta-migrating very-low-density lipoprotein with the lipoprotein remnant receptor unaffected. Eur J Biochem 1996 0.77
62 Complete down-regulation of low-density lipoprotein receptor activity in human liver parenchymal cells by beta-very-low-density lipoprotein. FEBS Lett 1991 0.77
63 Identification of an internalising peptide in differentiated Calu-3 cells by phage display technology; application to gene delivery to the airways. J Drug Target 2003 0.77
64 Transport of a hydrophilic compound into the cerebrospinal fluid during experimental allergic encephalomyelitis and after lipopolysaccharide administration. Pharm Res 1995 0.77
65 Characterization of the low-density-lipoprotein-receptor-independent interaction of beta-very-low-density lipoprotein with rat and human parenchymal liver cells in vitro. Biochem J 1992 0.77
66 The role of the low-density lipoprotein receptor-related protein (LRP) in the plasma clearance and liver uptake of recombinant single-chain urokinase-type plasminogen activator in rats. Thromb Haemost 1997 0.77
67 Design and synthesis of a multivalent homing device for targeting to murine CD22. Bioorg Med Chem 2001 0.76
68 A structure-function study of ligand recognition by CD22beta. J Biol Chem 2001 0.76
69 Mechanisms of tissue-type plasminogen activator (tPA) clearance by the liver. Ann N Y Acad Sci 1992 0.76
70 Lymphocyte and macrophage populations in the liver. Hepatogastroenterology 1996 0.76
71 Native and non-glycosylated recombinant single-chain urokinase-type plasminogen activator are recognized by different receptor systems on rat parenchymal liver cells. Thromb Haemost 1995 0.76
72 Characterization of the scavenger receptor on bovine cerebral endothelial cells in vitro. J Neurochem 1993 0.76
73 [Neuroleptic malignant syndrome in users of risperidone]. Ned Tijdschr Geneeskd 2005 0.75
74 Disturbance-free skin electrodes for persons during exercise. Med Biol Eng 1966 0.75
75 Fate and effects of 3,4-dichloroaniline (DCA) in marine plankton communities in experimental enclosures. Ecotoxicol Environ Saf 1984 0.75
76 The role of mast cells in atherosclerosis. Hamostaseologie 2014 0.75
77 Development of marine periphyton under mercury stress in a controlled ecosystem experiment. Bull Environ Contam Toxicol 1980 0.75
78 Fate and effects of mercury in marine plankton communities in experimental enclosures. Ecotoxicol Environ Saf 1981 0.75
79 Effect of cyclosporin A, cyclophosphamide on graft versus host reactions. Cell Biol Int Rep 1984 0.75
80 Characterization of the binding of urokinase-type plasminogen activator to the asialoglycoprotein receptor. Thromb Haemost 2002 0.75
81 Activation of rat Kupffer cells to tumoricidal cells by the immunomodulator muramyl tripeptide-phosphatidylethanolamine incorporated into the novel drug carrier lactosylated low density lipoprotein. Mol Pharmacol 1994 0.75
82 Ligand specificity of the LDL-receptor related protein. Z Gastroenterol 1996 0.75
83 [Recording of fetal heart action]. Ned Tijdschr Geneeskd 1965 0.75
84 Hepatocellular localisation of biosynthesis of vitronectin. Characterisation of the primary structure of rat vitronectin. Biochem Mol Biol Int 1995 0.75
85 [Fetal electrocardiogram and cardiotachogram during delivery (using skull electrodes and a computer)]. Ned Tijdschr Geneeskd 1965 0.75
86 Cardiac output monitoring in intensive care patients by radial artery pressure waveform analysis. Conf Proc IEEE Eng Med Biol Soc 2004 0.75
87 Graft versus host reaction in the rat: effect of cyclosporin A and cyclophosphamide on lymphocyte subsets involved in GvHR. Adv Exp Med Biol 1985 0.75
88 [New perspectives in fetal electrocardiography. Use of a recording device]. Ned Tijdschr Geneeskd 1965 0.75
89 Zonal distribution of receptor binding of trypsin-activated alpha 2-macroglobulin, alpha 2-macroglobulin receptor-associated protein, lactoferrin and transferrin on rat liver parenchymal cells. Biochim Biophys Acta 1995 0.75